Wolverine Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Wolverine Asset Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-47,000	Closed	-$2.26M	–	1934
2020 Q1	$2.26M	Buy	47,000 +23,900	+103%	+$1.11M	0.03%	331
2019 Q4	$1.08M	Buy	+23,100	New	+$1.02M	0.01%	600
2019 Q3	–	Sell	-77,000	Closed	-$2.31M	–	1715
2019 Q2	$2.31M	Buy	+77,000	New	+$1.76M	0.03%	402

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Wolverine Asset Management's RARX Position: Q2 2020 in Review

Wolverine Asset Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 47,000 shares — an estimated $2.26M sold.

Wolverine Asset Management first reported a position in RARX in Q2 2019 and held it in 3 quarters. The position peaked at $2.31M in Q2 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Wolverine Asset Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Wolverine Asset Management sold 47,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.26M.
Wolverine Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
Wolverine Asset Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.31M in Q2 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.